Veena Venugopalan

Veena Venugopalan, Pharm.D.

Clinical Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 265-0111
Business Email: vvenugopalan@cop.ufl.edu

About Veena Venugopalan

Veena Venugopalan received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy. Following graduation, she completed her pharmacy practice residency and infectious diseases specialty residency at the University of Kentucky Medical Center. As a board certified pharmacist with added qualifications in infectious diseases pharmacotherapy, Venugopalan has developed and maintained antimicrobial stewardship programs at large academic centers as well as community teaching hospitals. She joined the faculty at the University of Florida College of Pharmacy as an assistant professor in January 2016. She serves as the infectious diseases clinical specialist at UF Health Shands Hospital. Her research and patient care activities focus on health care associated infections, multidrug resistant gram-negative infections and antimicrobial stewardship. Her work has been published in peer-reviewed journals, and she has been presented at national and international conferences.

Research Profile

Research Interest: Antimicrobial stewardship practice, Multi-drug resistant gram-negative infections

Publications

2021
Impact of supplemental individual verbal defense on confidence, engagement, and performance in a team-based learning therapeutics course.
Currents in pharmacy teaching & learning. 13(2):152-158 [DOI] 10.1016/j.cptl.2020.09.010. [PMID] 33454072.
2021
Resource Over-Utilization in Hospitalized Patients With Uncomplicated Skin and Soft Tissue Infections.
Journal of pharmacy practice. [DOI] 10.1177/08971900211000216. [PMID] 33752488.
2020
An Update on Existing and Emerging Data for Meropenem-Vaborbactam.
Clinical therapeutics. 42(4):692-702 [DOI] 10.1016/j.clinthera.2020.01.023. [PMID] 32147146.
2020
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients.
The Journal of antimicrobial chemotherapy. 75(12):3644-3651 [DOI] 10.1093/jac/dkaa359. [PMID] 32910809.
2020
Letter to the editor (infection after penetrating brain injury).
The journal of trauma and acute care surgery. 88(3) [DOI] 10.1097/TA.0000000000002481. [PMID] 31425469.
2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing.
Antimicrobial agents and chemotherapy. 64(9) [DOI] 10.1128/AAC.00745-20. [PMID] 32601155.
2020
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections.
Open forum infectious diseases. 7(3) [DOI] 10.1093/ofid/ofaa051. [PMID] 32161775.
2019
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
Antimicrobial agents and chemotherapy. 63(11) [DOI] 10.1128/AAC.00788-19. [PMID] 31427300.
2019
Use of an Anti-Infective Medication Review Process at Hospital Discharge to Identify Medication Errors and Optimize Therapy.
Journal of pharmacy practice. 32(5):488-492 [DOI] 10.1177/0897190018761411. [PMID] 29534629.
2018
Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
International journal of antimicrobial agents. 52(5):719-723 [DOI] 10.1016/j.ijantimicag.2018.08.007. [PMID] 30125680.
2018
SCAN: A novel approach for vancomycin time-out.
Infection control and hospital epidemiology. 39(12):1501-1503 [DOI] 10.1017/ice.2018.249. [PMID] 30303049.
2018
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Microbiology insights. 11 [DOI] 10.1177/1178636118804549. [PMID] 30349291.
2017
Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice.
Infectious diseases (London, England). 49(11-12):867-870 [DOI] 10.1080/23744235.2017.1350880. [PMID] 28695756.
2017
Impact of an antimicrobial stewardship initiative on time to administration of empirical antibiotic therapy in hospitalized patients with bacteremia.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(7):511-519 [DOI] 10.2146/ajhp160096. [PMID] 28336761.
2017
Preparing Students to Enter the Race for Postgraduate Training.
Journal of pharmacy practice. 30(4):476-482 [DOI] 10.1177/0897190016645033. [PMID] 27194071.
2016
Administration of a survey to evaluate the attitudes of house staff physicians towards antimicrobial resistance and the antimicrobial stewardship programme at a community teaching hospital.
Journal of global antimicrobial resistance. 4:21-27 [DOI] 10.1016/j.jgar.2016.01.004. [PMID] 27436388.
2016
Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool.
The Journal of antimicrobial chemotherapy. 71(11):3268-3275 [PMID] 27494908.
View on: PubMed

Grants

Mar 2021 ACTIVE
Developing a Virtual Tour of the Microbiology Lab
Role: Principal Investigator
Funding: SOC OF INFECTIOUS DISEASES PHARMACISTS
Mar 2017 – Jun 2019
Effect of Subinhibitory Concentrations of Linezolid, Tedizolid, Clindamycin, and Vancomycin on Staphylokinase Production by Community-Associated Methicillin-Resistant Staphylococcus aureus and its Potential Implication on Influenza A/Staphylococcus aureus
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL

Education

Pharm.D.
2006 · University of Kentucky

Teaching Profile

Courses Taught
2016-2020
PHA5782C Patient Care 2
2016-2020
PHA5755 Micro, Immun, Virol
2017-2018
PHA5788C Patient Care 6
2018
PHA5759 Advanced Pharmacy Practice Experience Readiness

Contact Details

Phones:
Business:
(352) 265-0111
Emails: